About Us
ImmuneMed, Inc. utilizes human's own immunity against Infectious Diseases.
With the belief that it is the most basic solution,
we have been researching for many years.
Greeting
ImmuneMed, Inc. was established with the corporate goal of 'contributing to the healthy life of mankind free from infectious diseases.' We would like to ask our researchers who are working with the ever-day and night virus to open new horizons in medical history around the world.
R & D
We are conducting research with the belief that leveraging human immunity is the most basic solution to various diseases. We are developing and developing VSF (Virus Suppressing Factor), an antiviral source.
R & D
We are conducting research with the belief that leveraging human immunity is the most basic solution to various diseases. We are developing and developing VSF (Virus Suppressing Factor), an antiviral source.
Products
- COVID-19 Ag NPS,Nasal,Saliva Rapid
- Qualitative test to detect nucleocapsid protein antigens of SARS-CoV-2 existing in nasopharynx, nasal and saliva.
- COVID-19 Ag Rapid
- Qualitative Test to detect Ag specific antibodies to SARS-CoV-2 in human serum or plasma.
- Scrub Typhus Rapid
- Qualitative Test to detect antibody IgM and IgG specific to Orientia tsutsugamushi existing in human bloods(Serum, Plasma & Whole Blood).
- AFI Rapid
- Qualitative Test to detect antibody IgM and IgG specific to Leptospira, Orientia tsutsugamushi and Hantavirus existing in human bloods(Serum, Plasma & Whole Blood).
News & Press
Press
Release
Release
[Heliyon] hzVSF inhibits hepatitis B virus infection by targeting viral cell entry
2022-05-26
Press
Release
Release
[Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results
2022-05-26
Press
Release
Release
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
2021-01-08
Press
Release
Release
COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
2020-12-21